Research Article

Diagnostic value of delta neutrophil index in determining axillary metastases in breast cancer

Volume: 3 Number: 3 September 26, 2022
TR EN

Diagnostic value of delta neutrophil index in determining axillary metastases in breast cancer

Abstract

Aim: The delta neutrophil index (DNI), which shows the percentage of immature granulocytes (IG) in peripheral blood in inflammatory conditions, is an indicator of increased bone marrow activation. Its ability to predict prognosis has been demonstrated in many cancer studies. This study aims to investigate the value of DNI in predicting axillary metastases in breast cancer. Material and Method: Patients diagnosed with breast cancer and operated on axillary lymph node dissection were screened and 127 patients were included in the study. The patient’s age, gender, operation time, length of hospital stay, immature granulocyte (IG) percentages (IG#), and axillary lymph node pathology results were retrospectively scanned from the archive system. Results: DNI and IG were statistically higher in the group with lymph node metastasis. When examined for IG#, the mean of the group with reactive lymph nodes was 0.02±0.02, while the mean of the metastatic group was 0.04±0.05. This statistically significant difference was high (p<0.001). Cut-off values of 0.035 (OR 4.133, CI 95% 0.589-0.777, p<0.001) were found with 40% sensitivity and 86.1% specificity for the differentiation IG# of metastasis among patients. Conclusion: DNI and IG count may be new predictive markers with high sensitivity and specificity in detecting axillary metastasis of breast cancer.

Keywords

References

  1. Siegal R, Ma J, Zou Z, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2014; 64: 9-29.
  2. Marín Hernández C, Piñero Madrona A, Gil Vázquez PJ, et al. Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy. Clin Transl Oncol 2018; 20: 476-83.
  3. Chen F, Liu M, Yu Y, et al. LINC00958 regulated miR-627-5p/YBX2 axis to facilitate cell proliferation and migration in oral squamous cell carcinoma. Cancer Biol Ther 2019; 20: 1270-80.
  4. Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM. Influencetumormour stage at breast cancer detection on survival in modern times: population-based study in 173,797 patients. BMJ 2015; 351: 4901.
  5. Guthrie GJ, Charles KA, Roxburgh CS, et al. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 2013; 88: 218-30.
  6. McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009; 12: 223-6.
  7. Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014; 29: 106
  8. Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute’s Surveillance, Epidemiology, and End Results database. Cancer 2007; 110: 876-84

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

September 26, 2022

Submission Date

August 16, 2022

Acceptance Date

September 10, 2022

Published in Issue

Year 2022 Volume: 3 Number: 3

APA
Alkurt, E. G., & Tutan, M. B. (2022). Diagnostic value of delta neutrophil index in determining axillary metastases in breast cancer. Journal of Medicine and Palliative Care, 3(3), 216-220. https://doi.org/10.47582/jompac.1162371
AMA
1.Alkurt EG, Tutan MB. Diagnostic value of delta neutrophil index in determining axillary metastases in breast cancer. J Med Palliat Care / JOMPAC / jompac. 2022;3(3):216-220. doi:10.47582/jompac.1162371
Chicago
Alkurt, Ertugrul Gazi, and Mehmet Berksun Tutan. 2022. “Diagnostic Value of Delta Neutrophil Index in Determining Axillary Metastases in Breast Cancer”. Journal of Medicine and Palliative Care 3 (3): 216-20. https://doi.org/10.47582/jompac.1162371.
EndNote
Alkurt EG, Tutan MB (September 1, 2022) Diagnostic value of delta neutrophil index in determining axillary metastases in breast cancer. Journal of Medicine and Palliative Care 3 3 216–220.
IEEE
[1]E. G. Alkurt and M. B. Tutan, “Diagnostic value of delta neutrophil index in determining axillary metastases in breast cancer”, J Med Palliat Care / JOMPAC / jompac, vol. 3, no. 3, pp. 216–220, Sept. 2022, doi: 10.47582/jompac.1162371.
ISNAD
Alkurt, Ertugrul Gazi - Tutan, Mehmet Berksun. “Diagnostic Value of Delta Neutrophil Index in Determining Axillary Metastases in Breast Cancer”. Journal of Medicine and Palliative Care 3/3 (September 1, 2022): 216-220. https://doi.org/10.47582/jompac.1162371.
JAMA
1.Alkurt EG, Tutan MB. Diagnostic value of delta neutrophil index in determining axillary metastases in breast cancer. J Med Palliat Care / JOMPAC / jompac. 2022;3:216–220.
MLA
Alkurt, Ertugrul Gazi, and Mehmet Berksun Tutan. “Diagnostic Value of Delta Neutrophil Index in Determining Axillary Metastases in Breast Cancer”. Journal of Medicine and Palliative Care, vol. 3, no. 3, Sept. 2022, pp. 216-20, doi:10.47582/jompac.1162371.
Vancouver
1.Ertugrul Gazi Alkurt, Mehmet Berksun Tutan. Diagnostic value of delta neutrophil index in determining axillary metastases in breast cancer. J Med Palliat Care / JOMPAC / jompac. 2022 Sep. 1;3(3):216-20. doi:10.47582/jompac.1162371

Cited By

TR DİZİN ULAKBİM and International Indexes (1d)

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
 


 

download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiVHJfSW5kZXhfbG9nby5wbmciLCJwYXRoIjoiN2EzMC84NTVhL2UyMWMvNjlkZjRkZmVhNTUyNTYuNzg3NjU2ODgucG5nIiwiZXhwIjoxNzc2MjQ1Nzc0LCJub25jZSI6IjU0MDZkMWE2NmE1Y2QwZTJjNGYyNDA1OTM2MTE0YWIxIn0.Tt-WScFXTj5r2jji5eDMFApNzujLMjMPl8ivXRbozSI



f9ab67f.png
asos-index.png


 


download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiQ3Jvc3NyZWYuanBnIiwicGF0aCI6IjAzMzEvMTdkZi8yN2ZkLzY5ZGY0ZThhMDZkMjg0LjQxMjAyNDg5LmpwZyIsImV4cCI6MTc3NjI0NTkxNCwibm9uY2UiOiI2NjM1Yjc5MWFiY2I1MDQ0NjkzMTAxMDhjY2Y2NzRlMCJ9.5jDQBEY-KErkDK1QjDmv9ichOkNIn5CWYibe1Wz1644
icmje_1_orig.png
 
cc.logo.large.png
 
ncbi.png
 
google-scholar.pngpn6krf5.jpg
 


 

Our journal is in TR-Dizin, DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index, Eurasian Scientific Journal Index (ESJI), and Turkiye Citation Index.

EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation. 

 

Journal articles are evaluated as "Double-Blind Peer Review"